Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Renal Impairment
ASTX727-17
Phase 1 other active
Quick answer
Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Renal Impairment for Acute myeloid lymphoma (AML), myelodysplastic syndrome (MDS), or solid tumors is a Phase 1 program (other) at Taiho Pharma Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Taiho Pharma Netherlands B.V.
- Indication
- Acute myeloid lymphoma (AML), myelodysplastic syndrome (MDS), or solid tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active